600789 Shandong Lukang Pharmaceutical
- 7.60
- +0.06+0.80%
Shandong Lukang Pharmaceutical News
Shandong Lukang Pharmaceutical's announcement regarding the restrictive exercise period of stock option incentive plan
Shandong Lukang Pharmaceutical's announcement regarding the restrictive exercise period of stock option incentive plan
Announcement by Shandong Lukang Pharmaceutical regarding the results of the 2019 stocks options incentive plan for the second quarter of 2024 and changes in shareholding.
Shandong Lukang Pharmaceutical Announcement of Annual Equity Distribution in 2023
Shandong Lukang Pharmaceutical's announcement regarding the adjustment of the exercise price of the 2019 stock options compensation plan.
Legal Opinion of Beijing Tongshang Law Firm on the Adjustment of the 2019 Stock Option Incentive Plan Exercise Price of Shandong Lukang Pharmaceutical Co., Ltd.
An indicative announcement by Lu Kang Pharmaceutical on the period during which the stock option incentive plan restricts the exercise of rights
An indicative announcement by Lu Kang Pharmaceutical on the period during which the stock option incentive plan restricts the exercise of rights
Announcement of Lukang Pharmaceutical on the results of independent exercise of the 2019 Stock Options Incentive Plan for the first quarter of 2024 and stock changes
Announcement on the 2023 Profit Distribution Plan of Lukang Pharmaceutical
An indicative announcement by Lu Kang Pharmaceutical on the period during which the stock option incentive plan restricts the exercise of rights
Lukang Pharmaceutical\'s indicative announcement on the stock option incentive plan to limit the exercise period
Announcement of Lukang Pharmaceutical on the results of independent exercise of the 2019 Stock Options Incentive Plan for the fourth quarter of 2023 and stock changes
Lu Kangmedical\'s announcement on the completion of cancellation of unexercised stock options that have expired during the second exercise period of the 2019 Stock Options Incentive Plan
Lu Kang Pharmaceutical\'s implementation announcement on the third exercise period of the company\'s 2019 stock option incentive plan that meets the exercise conditions
Lu Kang Pharmaceutical\'s announcement on cancellation of unexercised stock options that have expired during the second exercise period of the 2019 Stock Option Incentive Plan
Legal opinion of Beijing Commerce Law Firm on the cancellation of unexercised stock options for which the second exercise period of the 2019 Stock Option Incentive Plan by Shandong Lukang Pharmaceutical Co., Ltd. has expired for the second exercise period
Lu Kang Pharmaceutical\'s announcement on the results of independent exercise and stock changes during the second exercise period of the 2019 Stock Option Incentive Plan
Legal opinion of Beijing Commerce Law Firm on Shandong Lukang Pharmaceutical Co., Ltd.\'s adjustment of the list of incentive recipients of the 2019 stock option incentive plan and the number of options granted, cancellation of some options, and the fulfil
Verification opinions of the Board of Supervisors on matters relating to the company\'s stock option incentive plan
Analysis
Price Target
No Data
